Efficacy and safety of subcutaneous clonidine for refractory symptoms in palliative medicine: a retrospective study.

Published in: BMJ supportive & palliative care (2022)

Subcutaneous administration of clonidine appears to be a promising alternative option for refractory symptoms in the last weeks of life. We suggest some possible next steps for further research.

Keyphrases

sleep quality
palliative care
gestational age
physical activity